Clearfield director awarded 326 common shares at $0 per share
Clearfield, Inc. director Kathleen Skarvan reported acquiring 326 shares of Clearfield common stock on 12/10/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Clearfield, Inc. director Kathleen Skarvan reported acquiring 326 shares of Clearfield common stock on 12/10/2025. The shares were acquired at a price of $0 per share, resulting in 326 shares beneficially owned after the transaction, all held as direct ownership. The filing notes that restrictions on these shares lapse on the one-year anniversary of the grant date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 326 | $0.00 | $0.00 |
Footnotes (1)
- F1. The restrictions on the shares lapse on the one year anniversary of the date of the grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Clearfield (CLFD) report on 12/10/2025?
The report shows that director Kathleen Skarvan acquired 326 shares of Clearfield, Inc. common stock on 12/10/2025 at a price of $0 per share.
What type of security is involved in this Clearfield Form 4 filing?
The filing involves Common Stock of Clearfield, Inc., with a reported acquisition of 326 shares.
Is the ownership reported as direct or indirect in this CLFD Form 4?
After the reported transaction, the 326 shares are listed as direct (D) beneficial ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.